2,189
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia

, , , , , , & show all
Pages 882-890 | Received 29 Mar 2017, Accepted 17 May 2017, Published online: 02 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rui-Jun Ju, Lan Cheng, Xiao Qiu, Shuang Liu, Xiao-Li Song, Xiao-Ming Peng, Teng Wang, Cui-Qing Li & Xue-Tao Li. (2018) Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels. Journal of Drug Targeting 26:9, pages 793-805.
Read now
Haibin Wu, Meng Wang, Bo Dai, Yanmin Zhang, Ying Yang, Qiao Li, Mingyue Duan, Xi Zhang, Xiaomei Wang, Anmao Li & Liyu Zhang. (2017) Novel CD123-aptamer-originated targeted drug trains for selectively delivering cytotoxic agent to tumor cells in acute myeloid leukemia theranostics. Drug Delivery 24:1, pages 1216-1229.
Read now

Articles from other publishers (17)

Elisabetta Mazzotta, Martina Romeo & Rita Muzzalupo. 2024. Molecular Pharmaceutics and Nano Drug Delivery. Molecular Pharmaceutics and Nano Drug Delivery 135 159 .
Azim Ansari, Afzal Hussain, Raju Wadekar, Mohammad A. Altamimi, Abdul Malik, Md Ali Mujtaba, Mohammad Yousuf Ansari, Mohd Usman Mohd Siddique & Sameer N. Goyal. (2023) Nanovesicles based drug targeting to control tumor growth and metastasis. Advances in Cancer Biology - Metastasis 7, pages 100083.
Crossref
Horacio Bach & Ana C. Lorenzo‐Leal. (2023) Use of niosomes for the treatment of intracellular pathogens infecting the lungs. WIREs Nanomedicine and Nanobiotechnology 15:4.
Crossref
Golchin Shafiei, Davoud Jafari-Gharabaghlou, Mahdi Farhoudi-Sefidan-Jadid, Effat Alizadeh, Marziyeh Fathi & Nosratollah Zarghami. (2023) Targeted delivery of silibinin via magnetic niosomal nanoparticles: potential application in treatment of colon cancer cells. Frontiers in Pharmacology 14.
Crossref
Ana Camila Marques, Paulo C. Costa, Sérgia Velho & Maria Helena Amaral. (2023) Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy. Pharmaceutics 15:1, pages 216.
Crossref
Mahmoud H. Teaima, Doaa A. Helal, Jihad M. Alsofany, Mohamed A. El-Nabarawi & Mohamed Yasser. (2022) Ion-Triggered In Situ Gelling Intranasal Spray of Dronedarone Hydrochloride Nanocarriers: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal. Pharmaceutics 14:11, pages 2405.
Crossref
Meichen Zhang, Yangyang Ge, Shilin Xu, Xiaocui Fang, Jie Meng, Lanlan Yu, Chenxuan Wang, Jian Liu, Tao Wen, Yanlian Yang, Chen Wang & Haiyan Xu. (2022) Nanomicelles co-loading CXCR4 antagonist and doxorubicin combat the refractory acute myeloid leukemia. Pharmacological Research 185, pages 106503.
Crossref
Jiaping Wang, Lixia Sheng, Yanli Lai & Zhijuan Xu. (2022) An overview on therapeutic efficacy and challenges of nanoparticles in blood cancer therapy. Journal of King Saud University - Science 34:6, pages 102182.
Crossref
Tianyuan Ci, Wentao Zhang, Yingyu Qiao, Huangjuan Li, Jing Zang, Hongjun Li, Nianping Feng & Zhen Gu. (2022) Delivery strategies in treatments of leukemia. Chemical Society Reviews 51:6, pages 2121-2144.
Crossref
Md Ishak Khan, M. Imran Hossain, M. Khalid Hossain, M. H. K. Rubel, K. M. Hossain, A. M. U. B. Mahfuz & Muzahidul I. Anik. (2022) Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review. ACS Applied Bio Materials 5:3, pages 971-1012.
Crossref
Tania Limongi, Francesca Susa, Monica Marini, Marco Allione, Bruno Torre, Roberto Pisano & Enzo di Fabrizio. (2021) Lipid-Based Nanovesicular Drug Delivery Systems. Nanomaterials 11:12, pages 3391.
Crossref
Denitsa B. Momekova, Viliana E. Gugleva & Petar D. Petrov. (2021) Nanoarchitectonics of Multifunctional Niosomes for Advanced Drug Delivery. ACS Omega 6:49, pages 33265-33273.
Crossref
Lina Jia, Peng Zhang, Hongyan Sun, Yuguo Dai, Shuzhang Liang, Xue Bai & Lin Feng. (2021) Optimization of Nanoparticles for Smart Drug Delivery: A Review. Nanomaterials 11:11, pages 2790.
Crossref
Alireza Soleimanian, Balal Khalilzadeh, Mahdi Mahdipour, Amir Reza Aref, Alireza Kalbasi, Sajad Razavi Bazaz, Majid Ebrahimi Warkiani, Mohammad Reza Rashidi & Majid Mahdavi. (2021) An Efficient Graphene Quantum Dots-Based Electrochemical Cytosensor for the Sensitive Recognition of CD123 in Acute Myeloid Leukemia Cells. IEEE Sensors Journal 21:15, pages 16451-16463.
Crossref
Xiao Huang, Hai Lin, Feng Huang, Yuning Xie, Ka Hong Wong, Xiaoyu Chen, Dongyue Wu, Aiping Lu & Zhijun Yang. (2019) Targeting Approaches of Nanomedicines in Acute Myeloid Leukemia. Dose-Response 17:4, pages 155932581988704.
Crossref
Jianfeng Guo, Xue Luan, Zhongcheng Cong, Yao Sun, Limei Wang, Sharon L. McKenna, Mary R. Cahill & Caitriona M. O'Driscoll. (2018) The potential for clinical translation of antibody-targeted nanoparticles in the treatment of acute myeloid leukaemia. Journal of Controlled Release 286, pages 154-166.
Crossref
Fereshteh Davarpanah, Aliakbar Khalili Yazdi, Mahmood Barani, Mohammad Mirzaei & Masoud Torkzadeh-Mahani. (2018) Magnetic delivery of antitumor carboplatin by using PEGylated-Niosomes. DARU Journal of Pharmaceutical Sciences 26:1, pages 57-64.
Crossref